Delivery Order SPE2DB20D1109-SPE2DB25FP16V
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on September 22, 2025, with a ceiling value of $14,105.35. This firm fixed-price delivery order, which is not set-aside, has an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $51,202.00 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 17, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $80,147.26 to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of RINVOQ ER 45 mg tablets in quantities of 28-count units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract has an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $29,158.33 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on September 17, 2025, with completion targeted for September 18, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,772.76 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical inventory supporting military healthcare operations. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units) under a firm fixed-price contract valued at $15,357.41. This non-set-aside delivery order, with an ultimate completion date of September 30, 2025, represents a procurement of pharmaceutical products to support federal medical supply requirements. The order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $16,181.74 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count packaging) on September 18, 2025, with a completion date of September 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single fulfillment under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $6,416.84 under a firm fixed-price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award utilizing the contractor's existing indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,136.53 for RINVOQ ER 15 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $32,555.23 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....